378 related articles for article (PubMed ID: 26278511)
1. Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.
Hu M; Patel SK; Zhou T; Rohan LC
J Control Release; 2015 Dec; 219():681-696. PubMed ID: 26278511
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV.
Zondo NM; Sobia P; Sivro A; Ngcapu S; Ramsuran V; Archary D
Front Genet; 2022; 13():940661. PubMed ID: 36246609
[TBL] [Abstract][Full Text] [Related]
3. Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention.
Nicol MR; Fedoriw Y; Mathews M; Prince HM; Patterson KB; Geller E; Mollan K; Mathews S; Kroetz DL; Kashuba AD
J Clin Pharmacol; 2014 May; 54(5):574-83. PubMed ID: 24343710
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of p-glycoprotein, multidrug resistance protein 4, and breast cancer resistance protein in the female lower genital tract of human and pigtailed macaque.
Zhou T; Hu M; Pearlman A; Patton D; Rohan L
AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1106-16. PubMed ID: 24803409
[TBL] [Abstract][Full Text] [Related]
5. Transporters for Antiretroviral Drugs in Colorectal CD4+ T Cells and Circulating α4β7 Integrin CD4+ T Cells: Implications for HIV Microbicides.
Mukhopadhya I; Murray GI; Duncan L; Yuecel R; Shattock R; Kelly C; Iannelli F; Pozzi G; El-Omar EM; Hold GL; Hijazi K
Mol Pharm; 2016 Sep; 13(9):3334-40. PubMed ID: 27467446
[TBL] [Abstract][Full Text] [Related]
6. Short communication: expression of transporters and metabolizing enzymes in the female lower genital tract: implications for microbicide research.
Zhou T; Hu M; Cost M; Poloyac S; Rohan L
AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1496-503. PubMed ID: 23607746
[TBL] [Abstract][Full Text] [Related]
7. Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure Prophylaxis.
Srinivas N; Cottrell M; Maffuid K; Prince HA; Nelson JAE; White N; Sykes C; Dellon ES; Madanick RD; Shaheen NJ; Gonzalez D; Kashuba ADM
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740561
[TBL] [Abstract][Full Text] [Related]
8.
Hijazi K; Iannelli F; Cuppone AM; Desjardins D; Caldwell A; Dereuddre-Bosquet N; Scala C; Smith KA; Mukhopadya I; Frank B; Gwozdz G; Santoro F; Grand RL; Pozzi G; Kelly C
Mol Pharm; 2020 Mar; 17(3):852-864. PubMed ID: 32017579
[TBL] [Abstract][Full Text] [Related]
9. Expression of membrane drug efflux transporters in the sigmoid colon of HIV-infected and uninfected men.
De Rosa MF; Robillard KR; Kim CJ; Hoque MT; Kandel G; Kovacs C; Kaul R; Bendayan R
J Clin Pharmacol; 2013 Sep; 53(9):934-45. PubMed ID: 23856938
[TBL] [Abstract][Full Text] [Related]
10. Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs.
Hijazi K; Cuppone AM; Smith K; Stincarelli MA; Ekeruche-Makinde J; De Falco G; Hold GL; Shattock R; Kelly CG; Pozzi G; Iannelli F
PLoS One; 2015; 10(6):e0131405. PubMed ID: 26102284
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
[TBL] [Abstract][Full Text] [Related]
12. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.
Patterson KB; Prince HA; Kraft E; Jenkins AJ; Shaheen NJ; Rooney JF; Cohen MS; Kashuba AD
Sci Transl Med; 2011 Dec; 3(112):112re4. PubMed ID: 22158861
[TBL] [Abstract][Full Text] [Related]
13. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
Krakower DS; Mayer KH
Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and cost-effectiveness of early antiretroviral therapy and partners' pre-exposure prophylaxis among men who have sex with men in Shenyang, China: a prospective cohort and costing study.
Hu QH; Meyers K; Xu JJ; Chu ZX; Zhang J; Ding HB; Han XX; Jiang YJ; Geng WQ; Shang H
BMC Infect Dis; 2019 Jul; 19(1):663. PubMed ID: 31345169
[TBL] [Abstract][Full Text] [Related]
16. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
[TBL] [Abstract][Full Text] [Related]
17. Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing.
Zhou T; Hu M; Pearlman A; Rohan LC
Biochem Pharmacol; 2016 Sep; 116():162-75. PubMed ID: 27453435
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral agents in pre-exposure prophylaxis: emerging and advanced trends in HIV prevention.
Yap PK; Loo Xin GL; Tan YY; Chellian J; Gupta G; Liew YK; Collet T; Dua K; Chellappan DK
J Pharm Pharmacol; 2019 Sep; 71(9):1339-1352. PubMed ID: 31144296
[TBL] [Abstract][Full Text] [Related]
19. Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming.
Hillis A; Germain J; Hope V; McVeigh J; Van Hout MC
AIDS Behav; 2020 Nov; 24(11):3056-3070. PubMed ID: 32274670
[TBL] [Abstract][Full Text] [Related]
20. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.
Mayer KH; Agwu A; Malebranche D
Adv Ther; 2020 May; 37(5):1778-1811. PubMed ID: 32232664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
